北京华睿鼎信科技

Beijing Huarui Dingxin Technology is a high-tech medical device company specializing in the research, development, and manufacturing of interventional cardiovascular products. The company focuses on drug-eluting technologies, particularly drug-coated balloons (DCB) and stents for treating coronary and peripheral vascular diseases. Its flagship products include sirolimus-eluting balloons designed to prevent restenosis after angioplasty without the need for permanent implants. Huarui Dingxin aims to provide stent-free clinical solutions to improve patient outcomes in vascular interventions. The company is headquartered in Beijing and maintains a strong R&D and manufacturing presence in China, with several products already receiving NMPA approval.